Abstract: Methods and apparatus are provided for handling data at a cryptography accelerator output interface. A shared resource such as a shared output buffer is provided at the cryptography accelerator output interface having multiple output ports. The output interface shared resource can be allocated amongst the various output ports based on characteristics and requirements of the various input ports. References to data in the shared resource allow processing and ordering of data following processing by cryptographic processing cores.

Abstract: Methods and apparatus are provided for decoupling a cryptography accelerator interface from cryptographic processing cores. A shared resource is provided at the cryptography accelerator interface having multiple input ports. References to data in the shared resource are provided to allow processing and ordering of data in preparation for processing by cryptographic processing cores without substantial numbers of separate buffers in the cryptographic processing data paths.

Abstract: Methods and apparatus are provided for handling data at a cryptography accelerator input interface. A shared resource is provided at the cryptography accelerator input interface having multiple input ports. The input interface shared resource can be allocated amongst the various input ports based on characteristics and requirements of the various input ports. References to data in the shared resource allow processing and ordering of data in preparation for processing by cryptographic processing cores.

Abstract: This invention relates to certain novel 2′-halomethylidene, 2′-ethenylidene and 2′-ethynyl cytidine, uridine and guanosine derivatives, and compositions thereof, which are useful in the treatment of patients afflicted with neoplastic or viral disease states.

Abstract: The present invention is directed to compounds represented by Structural Formula I and pharmaceutically acceptable salts, solvates and hydrates thereof, and methods of making, methods of using and pharmaceutical compositions having compounds represented by Structural Formula I and pharmaceutically acceptable salts, solvates and hydrates thereof: 1

Abstract: Methods and apparatus are provided for a cryptography accelerator to efficiently perform authentication and encryption operations. A data sequence is received at a cryptography accelerator. An encrypted authentication code and an encrypted data sequence is provided efficiently upon performing single pass authentication and encryption operations on the data sequence.

Abstract: The present invention is directed to compounds represented by Structural Formula I and pharmaceutically acceptable salts, solvates and hydrates thereof, and methods of making, methods of using and pharmaceutical compositions having compounds represented by Structural Formula I and pharmaceutically acceptable salts, solvates and hydrates thereof: In Structural Formula I, n is 2, 3, or 4; V is O or S; W is O, S, or SO2; R1 is H, a C1-C4 alkyl, phenyl or trifluoromethyl; R2 are each, independently, H, a C1-C6 alkyl, an aryl-C1-C6 alkyl, a cycloalkyl-C1-C4 alkyl, an aryl, a cycloalkyl, or together with the phenyl to which they are bound form naphthyl or 1,2,3,4-tetrahydronaphthyl; R3 are each, independently, H, a C1-C6 alkyl, an aryl-C1-C6 alkyl, a cycloalkyl-C1-C4 alkyl, an aryl, or a cycloalkyl; R4 are each, independently, H, a C1-C4 alkyl, an aryl, or benzyl; R5 are each, independently, H, a substituted or unsubstituted aryl or a heteroaryl, provided that at least one R5 is a substituted or u

Abstract: This invention relates to certain novel 2′-halomethylidene, 2′-ethenylidene and 2′-ethynyl cytidine, uridine and guanosine derivatives, and compositions thereof, which are useful in the treatment of patients afflicted with neoplastic or viral disease states.

Abstract: The system and method of the present invention facilitates encrypting and decrypting files using a fast hardware implementation of the RC4 method to enable secure access to information resources in a computer network. The network system includes a sender computer coupled via a computer network to a receiver computer. The RC4 algorithm as implemented in hardware and its associated multiport memory (included within both the sender computer and the receiver computer) enables a fast hardware implementation of the respective encryption circuit and decryption circuit. Multi-port memory allows for at either computer site a fast hardware implementation of the RC4 encryption/decryption method where reads and writes are synchronously performed.

Abstract: The present invention is directed to compounds represented by Structural Formula I and pharmaceutically acceptable salts, solvates and hydrates thereof, and methods of making, methods of using and pharmaceutical compositions having compounds represented by Structural Formula I and pharmaceutically acceptable salts, solvates and hydrates thereof: 1

Abstract: Methods and apparatus are provided for improving ARC4 processing in a cryptography engine. A multiple ported memory can be used to allow pipelined read and write access to values in memory. Coherency checking can be applied to provide that read-after-write and write-after-write consistency is maintained. Initialization of the memory can be improved with a reset feature occurring in a single cycle. Key shuffle and key stream generation can also be performed using a single core.

Abstract: Method and apparatus is provided for securely configuring a programmable hardware device from a remote source. The programmable hardware device includes a plurality of programmable logic modules. A host receives configuration information from the remote source, where the configuration information defines a function of the programmable logic modules. The host encrypts the configuration information according to a cryptographic algorithm. The encrypted information is transferred to a special download engine at the programmable hardware device, which decrypts the information according to the same cryptographic algorithm. The programmable logic modules are thus configured by the decrypted configuration information, which has been securely downloaded from the remote source.

Abstract: Method and apparatus is provided for securely configuring a programmable hardware device from a remote source. The programmable hardware device includes a plurality of programmable logic modules. A host receives configuration information from the remote source, where the configuration information defines a function of the programmable logic modules. The host encrypts the configuration information according to a cryptographic algorithm. The encrypted information is transferred to a special download engine at the programmable hardware device, which decrypts the information according to the same cryptographic algorithm. The programmable logic modules are thus configured by the decrypted configuration information, which has been securely downloaded from the remote source.

Abstract: The present invention is directed to compounds represented by Structural Formula I and pharmaceutically acceptable salts, solvates and hydrates thereof, and methods of making, methods of using and pharmaceutical compositions having compounds represented by Structural Formula I and pharmaceutically acceptable salts, solvates and hydrates thereof: In Structural Formula I, n is 2, 3, or 4; V is O or S; W is O, S, or SO2; R1 is H, a C1-C4 alkyl, phenyl or trifluoromethyl; R2 are each, independently, H, a C1-C6 alkyl, an aryl-C1-C6 alkyl, a cycloalkyl-C1-C4 alkyl, an aryl, a cycloalkyl, or together with the phenyl to which they are bound form naphthyl or 1,2,3,4-tetrahydronaphthyl; R3 are each, independently, H, a C1-C6 alkyl, an aryl-C1-C6 alkyl, a cycloalkyl-C1-C4 alkyl, an aryl, or a cycloalkyl; R4 are each, independently, H, a C1-C4 alkyl, an aryl, or benzyl; R5 are each, independently, H, a substituted or unsubstituted aryl or a heteroaryl, provided that at least one R5 is a substituted or u

Abstract: Provided is an architecture for a cryptography accelerator chip that allows significant performance improvements over previous prior art designs. The chip architecture enables a degree of parallel processing of authentication and encryption/decryption functions achieved by an alignment logic configuration that distinguishes portions of a non-pre-padded network security protocol (e.g., SSL (v3) or TLS) packet requiring one and/or another operation (authentication and/or encryption) to permit single pass processing of non-pre-padded network security protocol data. In some embodiments, processing efficiency may be further enhanced by the pipelining of successive packets to be processed.

Abstract: A system and method are provided for performing modulo multiplication of two numbers N bits long with a modulus of 2N+1, where the resulting modulus is determined without a need to perform successive reductions. Without a need to perform successive reductions, a hardware implementation does not require a divider circuit.

Abstract: A keyboard input device includes a processor repeatedly executing a scan routine to detect key press events while masking the events from an external monitoring means. The keyboard input device has a number of finger-activatable keys, each connected at the intersection of row signal lines and column signal lines, which are in turn connected to the processor. The processor systematically activates the rows and randomly activates the columns. A key press event causes the key's associated row and column to create a closed switch. The processor monitors the columns for a signal forced on pairs of rows. Obfuscating signals forced onto the columns inhibit detection of the key press event signals by an external source.

Abstract: This invention relates to certain novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives, and compositions thereof, which are useful in the treatment of patients afflicted with neoplastic or viral disease states.

Abstract: This invention relates to certain novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives, and compositions thereof, which are useful in the treatment of patients afflicted with neoplastic or viral disease states.

Abstract: The present invention is directed toward a novel process of preparing 2'-exocyclic vinylfluoride derivatives of cytidine analogues for use as ribonucleotide reductase inhibitors.